Tempest Therapeutics Inc (TPST) — Strategic Asset Allocation Index
Tempest Therapeutics Inc (TPST) has a Strategic Asset Allocation Index of 235.6% as of June 2023. Strategic assets (PP&E of $11.81 Million plus long-term investments of $-) total $11.81 Million, measured against net assets of $5.01 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Tempest Therapeutics Inc Strategic Asset Allocation Index (2019–2021)
This chart shows how Tempest Therapeutics Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2019 to 2021. As of June 2023, the index stands at 235.6%, representing strategic assets of $11.81 Million against net assets of $5.01 Million USD. Explore Tempest Therapeutics Inc (TPST) cash conversion ratio to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Tempest Therapeutics Inc (2019–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Tempest Therapeutics Inc from 2019 to 2021, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Tempest Therapeutics Inc worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 11.5% | $4.16 Million | $4.16 Million | $- | $36.12 Million | ▲ +5.3 pp |
| 2019 | 6.3% | $3.75 Million | $3.75 Million | $- | $59.87 Million | — |